/
/
/

Lincoln Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)603.00
Volume (₹)6,117.00
High (₹)604.35
Upper Circuit724.25
Low (₹)595.05
Lower Circuit482.85
Prev Close603.55
52W High (₹)770.00
Price597.35
52W Low (₹)440.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)1207.79 Cr
Div. Yield (%)0.30
PE Ratio12.52
Debt to Equity0.00
Price to Book1.64
Book Value335.34
EPS (TTM)48.15
Face Value10.00
ROE (%)13.02

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
LINCOLNNSE
LTP
1W Low
1W High
Market cap (₹)
1859.7+22.4 (1.22%)
1832.20
1891.50
4,47,476Cr
9617+242 (2.58%)
9312.50
9740
2,54,764Cr
4956+116 (2.40%)
4848.50
5010
1,89,423Cr
1177.6+17.6 (1.52%)
1152.10
1184.80
1,16,658Cr
1400+5.5 (0.39%)
1364.50
1405.20
1,11,484Cr
2046.1+92.1 (4.71%)
1963.80
2055.30
1,09,943Cr
2494.4+193.7 (8.42%)
2303
2502.70
1,01,712Cr
1205.2+20.2 (1.70%)
1185
1222
1,01,005Cr
1732.3-1.7 (-0.10%)
1689.30
1740
99,253Cr
2106.5+23.5 (1.13%)
2080
2135
96,031Cr
597.35-7.5 (-1.24%)
590.35
612
1,208Cr

Key Highlights of Lincoln Pharmaceuticals Ltd Balance Sheet

Lincoln Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹20.03Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹20.03Cr, and the reserves and surplus of the company is ₹651.64Cr.

The company has its non-current liabilities with total liabilities of ₹821.74Cr as of 2025-03-31.

The current liabilities are ₹130.95Cr as of 2025-03-31. At the same time, current assets are ₹524.62Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹5.26Lakh and tangible assets of ₹181.97Cr, provided in the Lincoln Pharmaceuticals Ltd financial statements.